Abstract
The resection of the primary tumor in patients with metastatic prostate cancer is controversially debated. Retrospective clinical studies indicate survival benefits and prevention of secondary, locoregional complications;however, results of ongoing multicenter prospective studies are still lacking. This review highlights the rationale behind the cytoreductive prostatectomy and summarizes current clinical study results.
| Dokumententyp: | Zeitschriftenartikel | 
|---|---|
| Fakultät: | Medizin | 
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit | 
| ISSN: | 0340-2592 | 
| Sprache: | Deutsch | 
| Dokumenten ID: | 50115 | 
| Datum der Veröffentlichung auf Open Access LMU: | 14. Jun. 2018 09:42 | 
| Letzte Änderungen: | 04. Nov. 2020 13:27 | 
		
	